JP2016521684A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521684A5 JP2016521684A5 JP2016515094A JP2016515094A JP2016521684A5 JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5 JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- hypochlorous acid
- magnesium
- amount
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 12
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 5
- 229910019142 PO4 Inorganic materials 0.000 claims 5
- 239000011777 magnesium Substances 0.000 claims 5
- 229910052749 magnesium Inorganic materials 0.000 claims 5
- 239000010452 phosphate Substances 0.000 claims 5
- -1 phosphate anion Chemical class 0.000 claims 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 4
- 239000011575 calcium Substances 0.000 claims 4
- 229910052791 calcium Inorganic materials 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 3
- 150000001768 cations Chemical class 0.000 claims 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 3
- 235000019799 monosodium phosphate Nutrition 0.000 claims 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims 2
- 230000000813 microbial effect Effects 0.000 claims 2
- 239000003002 pH adjusting agent Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 1
- 238000012084 abdominal surgery Methods 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361826382P | 2013-05-22 | 2013-05-22 | |
| US61/826,382 | 2013-05-22 | ||
| PCT/US2014/039202 WO2014190184A1 (en) | 2013-05-22 | 2014-05-22 | Stabilized hypochlorous acid solution and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016521684A JP2016521684A (ja) | 2016-07-25 |
| JP2016521684A5 true JP2016521684A5 (https=) | 2017-06-29 |
| JP6416227B2 JP6416227B2 (ja) | 2018-10-31 |
Family
ID=51934166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515094A Expired - Fee Related JP6416227B2 (ja) | 2013-05-22 | 2014-05-22 | 安定化次亜塩素酸溶液及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9918477B2 (https=) |
| EP (1) | EP2999341B1 (https=) |
| JP (1) | JP6416227B2 (https=) |
| CA (1) | CA2913137A1 (https=) |
| MX (1) | MX373524B (https=) |
| WO (1) | WO2014190184A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1993571B1 (en) | 2006-01-20 | 2018-07-25 | Sonoma Pharmaceuticals, Inc. | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
| EP2999341B1 (en) | 2013-05-22 | 2018-11-28 | Sonoma Pharmaceuticals, Inc. | Stabilized hypochlorous acid solution and use thereof |
| CN111032060A (zh) | 2017-06-28 | 2020-04-17 | 科利迪恩公司 | 用于清洁、消毒和/或灭菌的组合物、方法和用途 |
| SG11202006664UA (en) | 2018-01-14 | 2020-08-28 | Collidion Inc | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating |
| EP3927351A4 (en) | 2019-02-20 | 2023-01-04 | Biiosmart Technologies LLC | INTRAVENOUS HYPOCHLOROUS ACID SOLUTION, PREPARATION AND METHOD OF USE THEREOF |
| CA3167941A1 (en) | 2020-02-14 | 2021-08-19 | Collidion, Inc. | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating |
| LU101842B1 (en) | 2020-06-08 | 2021-12-08 | Arnaud Mainnemare | Pharmaceutical Composition for treating or preventing lesions and infections in a mammal |
| US11097945B1 (en) | 2020-11-04 | 2021-08-24 | Cougar Creek Electrolysed Water, Llc | Methods and systems for production of an aqueous hypochlorous acid solution |
| IT202000028082A1 (it) | 2020-11-23 | 2022-05-23 | Md Italy Srl | Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001041571A1 (en) * | 1999-12-10 | 2001-06-14 | Kao Corporation | Microbicide compositions |
| JP3554749B2 (ja) * | 2001-02-22 | 2004-08-18 | 株式会社アクシス | 殺菌消毒剤 |
| AU2004311432A1 (en) | 2003-12-30 | 2005-07-21 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution, processes for producing same and methods of using the same |
| US20050139808A1 (en) | 2003-12-30 | 2005-06-30 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and process for producing same |
| US9168318B2 (en) | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
| US20050196462A1 (en) | 2003-12-30 | 2005-09-08 | Oculus Innovative Sciences, Inc. | Topical formulation containing oxidative reductive potential water solution and method for using same |
| CA2602522C (en) | 2005-03-23 | 2014-09-09 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
| CN101163492B (zh) | 2005-03-23 | 2013-01-30 | 奥古露丝创新科学公司 | 利用氧化还原电位水溶液治疗2度和3度烧伤的方法 |
| BRPI0610901B1 (pt) | 2005-05-02 | 2019-04-16 | Oculus Innovative Sciences, Inc. | Uso de uma solução aquosa de potencial oxi-redutivo (orp). |
| EP1993571B1 (en) | 2006-01-20 | 2018-07-25 | Sonoma Pharmaceuticals, Inc. | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
| EP2136819A1 (en) | 2007-03-13 | 2009-12-30 | Oculus Innovative Sciences, Inc. | Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same |
| WO2010148004A1 (en) | 2009-06-15 | 2010-12-23 | Oculus Innovative Sciences, Inc. | Solution containing hypochlorous acid and methods of using same |
| BR112012006891A2 (pt) | 2009-07-30 | 2019-09-24 | Oculus Innovative Sciences Inc | formulação de hydrogel compreendendo uma solução aquosa com potencial oxidativo redutivo |
| GB2488838A (en) * | 2011-03-11 | 2012-09-12 | Biomimetics Health Ind Ltd | A stable antimicrobial aqueous hypochlorous acid solution |
| EP2999341B1 (en) | 2013-05-22 | 2018-11-28 | Sonoma Pharmaceuticals, Inc. | Stabilized hypochlorous acid solution and use thereof |
-
2014
- 2014-05-22 EP EP14801652.0A patent/EP2999341B1/en not_active Not-in-force
- 2014-05-22 MX MX2015016057A patent/MX373524B/es active IP Right Grant
- 2014-05-22 US US14/893,448 patent/US9918477B2/en active Active
- 2014-05-22 CA CA2913137A patent/CA2913137A1/en not_active Abandoned
- 2014-05-22 WO PCT/US2014/039202 patent/WO2014190184A1/en not_active Ceased
- 2014-05-22 JP JP2016515094A patent/JP6416227B2/ja not_active Expired - Fee Related
-
2018
- 2018-03-20 US US15/926,927 patent/US10412969B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016521684A5 (https=) | ||
| JP2012530142A5 (https=) | ||
| JP2022075813A (ja) | ジクアホソル含有点眼液 | |
| JP2014515737A5 (https=) | ||
| MX2020014000A (es) | Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas. | |
| MX2016006197A (es) | Formulaciones de compuestos de azaindol. | |
| RU2015126801A (ru) | Фторид-стабильные цинкосодержащие композиции для ухода за полостью рта | |
| JP2009523832A5 (https=) | ||
| WO2011109799A8 (en) | Nuclear transport modulatiors and uses thereof | |
| JP2010514799A5 (https=) | ||
| RU2012155188A (ru) | Композиции для ухода за полостью рта, устойчивые к микробному росту | |
| MY161032A (en) | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate | |
| CN104488957A (zh) | 循环水系统用高效复合杀菌剂及其制备方法 | |
| EP4631569A3 (en) | Alginate film comprising a triptan | |
| PH12015501793B1 (en) | Bicyclic compounds | |
| MX2015016057A (es) | Solucion estabilizada de acido hipocloroso y uso de la misma. | |
| WO2013086243A3 (en) | Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease | |
| NZ598490A (en) | Treatment of macular degeneration | |
| BR112014004111A2 (pt) | peneira molecular de silicoaluminofosfato e método de produção da mesma | |
| JP2013509378A5 (https=) | ||
| JP2018511644A5 (https=) | ||
| JP2015521598A5 (https=) | ||
| CN105410021A (zh) | 一种无刺激日用消毒水 | |
| TW200833708A (en) | Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture | |
| TW200745155A (en) | Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid |